Exchange: NASDAQ·Updated 01:23 PM EDT
LIMN logo

LIMN Liminatus Pharma Inc.

$3.71
$0.0075
(0.20%)
Today
Mkt Cap$4.97M
Vol16,398.00

About LIMN

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
41

Bearish Sentiment

How do you feel about LIMN?

Advertisement|Remove ads.